Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
Apr 7, 2026, 17:30

Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home

Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:

“Short answer (guideline-based):
No routine VTE prophylaxis for chronically bedridden patients at home.

Guideline Position

American College of Chest Physicians (CHEST Guidelines)
Do NOT recommend pharmacologic prophylaxis for:

  • Chronically immobilized patients
  • Nursing home residents
  • Home-bound patients without acute illness

Rationale:

  • Lower VTE incidence vs hospitalized patients
  • Higher bleeding risk outweighs benefit

American Society of Hematology (ASH 2018/2021 VTE Guidelines)

Suggest against routine prophylaxis in:

  • Long-term immobile patients at home
  • Unless additional strong transient risk factors present

When to consider prophylaxis (exception cases)

Only if high-risk transient state, e.g.:

  • Recent hospitalization (≤45–90 days)
  • Active cancer (especially + chemo)
  • Prior VTE
  • Acute infection/inflammation
  • Marked reduced mobility with additional risk (improve score high)

In such cases short-term prophylaxis may be considered (case-by-case)

Extended prophylaxis trials (important nuance)

  • MAGELLAN trial
  • APEX trial
  • MARINER trial

Show benefit in selected high-risk recently hospitalized patients, not applicable to stable chronically bedridden home patients

Practical Hematology Take
Bedridden alone isn’t indication

Always balance:
VTE risk vs bleeding risk

Focus on:

  • Hydration
  • Mobilization if possible
  • Reassess if clinical status changes

Key References

  • Kahn SR et al. CHEST Guideline (2012, updated concepts)
  • Spyropoulos AC et al., MARINER Trial (NEJM 2018)
  • Cohen AT et al., MAGELLAN Trial (NEJM 2013)

One-line clinical answer

No routine pharmacologic VTE prophylaxis for chronically bedridden patients at home unless additional high-risk transient factors are present.”

Stay updated with Hemostasis Today.

American college of Chest Physicians American Society of Hematology ASH Blood Chokri Ben Lamine Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine thrombosis venous thromboembolism VTE VTE Prophylaxis
NewsFeed